Company
Aardvark Therapeutics
Rethinking Metabolic Health
Also known as Aardvark Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Aardvark Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic diseases.
Funding snapshot
- Total raised
- $103MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $85M2024-05-01
Funding rounds
- Round, 2024
- $85M2024-05-01, SEC form D sold, 31 investors
- Round, 2021
- $9.1M2021-05-26, SEC form D sold, 8 investors
- Round, 2019
- $9M2019-05-17, SEC form D sold, 12 investors
Products
- Other
- ARD-101
Loading relationship preview